A study of P2X1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors

被引:68
|
作者
Vial, C
Rolf, MG
Mahaut-Smith, MP
Evans, RJ
机构
[1] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England
[2] Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England
关键词
P2X(1); P2Y; P2; receptor; platelets; megakaryocytes; Ca2(+)](i)(+); knock-out mice; synergy; Ca2(+) flux; CD; 41;
D O I
10.1038/sj.bjp.0704486
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We have examined the role of ATP-dependent P2X(1) receptors in megakaryocytes (MKS) and platelets using receptor-deficient mice and selective agonists. 2 alpha,beta-meATP- and ATP- evoked ionotropic inward currents were absent in whole-cell recordings frorn MKS of P2X(1)(-/-) mice, demonstrating that the P2X receptor phenotype in MKs, and by inference, platelets, is due to expression of homomeric P2X(1) receptors. 3 P2X(1) receptor deficiency had no effect on MK (CD 41) numbers or size distribution, showing that it is not essential for normal MK development. 4 P2Y receptor-stimulated [Ca2+](i) responses were unaffected in MKs from P2X(1)(-/-) mice, however the inward cation current associated with Ca2+ release was reduced by similar to50%, suggesting an interaction between the membrane conductances activated by P2X(1) and P2Y receptors. 5 Interaction between P2X(1) and P2Y receptors in human platelets was also examined using [Ca2+](i) recordings from cell suspensions. alpha,beta-meATP (10 muM) evoked a rapid transient P2X(1) receptor-mediated increase in [Ca2+](i), whereas ADP-(10 muM) evoked P2Y receptor responses were slower, peaked at a higher level and remained elevated for longer periods. Co-application of alpha,beta-meATP and ADP resulted in marked acceleration and amplification of the peak [Ca2+](i) response. 6 We conclude that ionotropic P2X(1) receptors may play a priming role in the subsequent activation of metabotropic P2Y receptors during platelet stimulation.
引用
收藏
页码:363 / 372
页数:10
相关论文
共 50 条
  • [21] P2Y1 and P2X1 nucleotide receptors are distributed differently along the human placenta vessels
    Delpiano, AM
    Buvinic, S
    Poblete, MI
    Donoso, V
    Miranda, R
    Huidobro-Toro, JP
    PLACENTA, 2006, 27 (01) : A51 - A51
  • [22] ADP can induce aggregation of human platelets via both P2Yι and P2τ receptors
    Jarvis, GE
    Humphries, RG
    Robertson, MJ
    Leff, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 : U20 - U20
  • [23] Differential sensitivity of human platelet P2X1 and P2Y1 receptors to disruption of lipid rafts
    Vial, C
    Fung, CYE
    Goodall, AH
    Mahaut-Smith, MP
    Evans, RJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 343 (02) : 415 - 419
  • [24] The P2Y Nucleotide Receptors in the Human Genome
    J. Simon
    E. A. Barnard
    Acta Biologica Hungarica, 2003, 54 : 191 - 201
  • [25] The P2Y nucleotide receptors in the human genome
    Simon, J
    Barnard, EA
    ACTA BIOLOGICA HUNGARICA, 2003, 54 (02): : 191 - 201
  • [26] NF449 and MRS2179 are useful tools to distinguish between P2X1 and P2Y1 receptors in human platelets
    Menke, K
    Horner, S
    Mahaut-Smith, M
    Hildebrandt, C
    Kassack, M
    Nickel, P
    Lambrecht, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R35 - R35
  • [27] GRK2 Regulates ADP Signaling in Platelets Via P2Y 1 and P2Y 12
    Zhao, Xuefei
    Cooper, Matthew
    Yarman, Yanki
    Baltz, Aiden
    Michael, James V.
    McKenzie, Steven E.
    Stalker, Timothy J.
    Zhu, Li
    Ma, Peisong
    BLOOD, 2021, 138
  • [28] Medicinal chemistry of adenosine, P2Y and P2X receptors
    Jacobson, Kenneth A.
    Mueller, Christa E.
    NEUROPHARMACOLOGY, 2016, 104 : 31 - 49
  • [29] Design of new antagonists of P2X and P2Y receptors
    Mueller, Christa
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [30] HEK293 human embryonic kidney cells endogenously express the P2Y(1) and P2Y(2) receptors
    Schachter, JB
    Sromek, SM
    Nicholas, RA
    Harden, TK
    NEUROPHARMACOLOGY, 1997, 36 (09) : 1181 - 1187